Delivery Order SPE2DB22D3301-SPE2DB25FX5ZQ

Award Date 11/22/24
Potential Completion Date 11/25/24
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,312.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of PROPRANOLOL ER 60 MG CAPSULE 100S. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,274.73, is for the delivery of 100 units of PROPRANOLOL ER 80 MG CAPSULE, a cardiovascular medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $1,004.70, is for the delivery of 4568250807 - PROPRANOLOL ER 60 MG CAPSULE 100S. The contract is a firm fixed-price delivery order with a period of performance through May 15, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $54,292.73 firm fixed-price delivery order is for the supply of PROPRANOLOL ER 160 MG CAPSULE 100S, a cardiovascular medication. The award has an ultimate completion date of January 23, 2025. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,828.56, is a Firm Fixed Price Delivery Order for the supply of PROPRANOLOL ER 120 MG CAPSULE 100S, a cardiovascular medication. The contract does not have a set-aside designation, indicating it was awarded through open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,787.34 firm fixed-price delivery order is for the supply of 4567408345 PROPRANOLOL ER 160 MG CAPSULE 100S, with a completion date of February 28, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
This federal contract award, valued at $1,034.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566866838 PROPRANOLOL ER 80 MG CAPSULE 100S, a cardiovascular medication, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a performance period through January 9, 2025. Amerisourcebergen holds a significant...
This federal contract award, with ID SPE2DB20D7059|SPE2DB25FPWZ6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,305.03 firm fixed-price delivery order is for the supply of 4566782703 - PROPRANOLOL ER 80 MG CAPSULE 100S. The contract has an ultimate completion date of December 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award, valued at $4,834.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567317540 PROPRANOLOL ER 60 MG CAPSULE 100S, a cardiovascular medication, with a performance period through February 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,087.58, is for the delivery of PROPRANOLOL ER 80 MG CAPSULE 100S, a cardiovascular medication. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX5ZQ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award, valued at $4,360.69, is a Delivery Order contract for the supply of the pharmaceutical product PROPRANOLOL ER 60 MG CAPSULE 100S. The contract has a completion date of November 25, 2024 and utilizes a Firm Fixed Price pricing type.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the DLA. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

This particular contract award was not designated with any set-aside requirements, indicating open competition. The award supports the DLA's mission of providing medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 5/20/25, 1:52 PM